On Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share ...

Buy Pfizer Ltd. at a price target of Rs 2900.

Pfizer East India will acquire 29 per cent and 31 per cent in the company from the Netherlands and Panama units, respectively.

The company said that a unit of its parent Pfizer Inc will buy about 61 per cent stake from two other units after an internal restructuring.

Net sales of the company stood at Rs 229.78 crore for the quarter under consideration against Rs 251.88 crore for the year-ago period.

Biocon is now exploring new partnerships with pharma companies for its biosimilars, or low-cost copies of biotechnology products.

Pfizer has identified oncology as the therapeutic segment for research in emerging markets such as China and India as cancer is one of the ...

The agreement includes the commercialisation of Biocon’s biosimilar versions of insulin and insulin analog products: recombinant human insu...

Biocon surged on buzz that Pfizer is in talks to buy a stake or strike a marketing alliance with it.

Pharma firm Pfizer India on Monday said the open offer by its parent firm for acquiring an additional 34 per cent stake in it has been resc...

US-based pharmaceutical giant Pfizer said its $ 136 mn (Rs 680 crore) open offer to shareholders of its Indian arm will begin on June 10.

Pfizer Investments Netherlands BV, a wholly-owned subsidiary of Pfizer, on Monday said it will make a tender offer to acquire an additional...

Pfizer Investments Netherlands BV on Monday said it will make a tender offer to acquire an additional 33.77% stake in Pfizer India from pub...

A possible counter offer by US giant Pfizer to buy 65% non-promoter stake in Ranbaxy is just a “market speculation”, a source close to the ...

The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...

Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities i...

The recent exit of the world’s largest drug-maker Pfizer Inc’s CFO Alan Levin may have an India angle if the allegations of a US-based blog...